GROUP ONE TRADING, L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952. A total of 4 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$50,984,000
+28.4%
2,193,800
-12.0%
0.44%
+9.0%
Q1 2018$39,703,000
-41.9%
2,493,900
-24.2%
0.40%
-16.7%
Q4 2017$68,335,000
+86.9%
3,288,500
+28.9%
0.48%
+44.6%
Q3 2017$36,556,000
-12.0%
2,551,000
+6.2%
0.33%
-23.1%
Q2 2017$41,558,000
+77.0%
2,402,200
+12.8%
0.43%
+58.2%
Q1 2017$23,485,000
-4.8%
2,129,200
+25.3%
0.27%
+14.2%
Q4 2016$24,681,000
-20.8%
1,699,800
+33.9%
0.24%
-29.3%
Q3 2016$31,176,000
+55.6%
1,269,900
+27.7%
0.34%
+42.6%
Q2 2016$20,031,000
-50.9%
994,600
-35.9%
0.24%
-58.9%
Q1 2016$40,815,000
-74.7%
1,551,900
-2.3%
0.58%
-69.8%
Q4 2015$161,430,000
+133.8%
1,588,100
+310.3%
1.91%
+99.8%
Q3 2015$69,051,000
+25.7%
387,100
+56.5%
0.96%
+24.2%
Q2 2015$54,938,000
+17.6%
247,300
+5.1%
0.77%
+4.8%
Q1 2015$46,735,000
-20.4%
235,300
-42.6%
0.73%
-17.2%
Q4 2014$58,704,000
+92.4%
410,200
+76.4%
0.89%
+88.5%
Q3 2014$30,504,000
+59.1%
232,500
+53.0%
0.47%
+59.3%
Q2 2014$19,170,000
+50.4%
152,000
+57.2%
0.30%
+37.9%
Q1 2014$12,748,000
+135.0%
96,700
+109.3%
0.21%
+161.0%
Q4 2013$5,424,000
+45.2%
46,200
+29.1%
0.08%
+13.9%
Q3 2013$3,735,000
-45.9%
35,800
-55.4%
0.07%
-57.6%
Q2 2013$6,904,00080,2000.17%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
Valtura Capital Partners LLC 1,511,600$39,755,0001.68%
SIMPLEX TRADING, LLC 11,589$17,876,0001.42%
GLENHILL ADVISORS LLC 26,953$16,279,0000.99%
GROUP ONE TRADING, L.P. 1,551,900$40,815,0000.58%
Marathon Trading Investment Management LLC 96,700$2,543,0000.48%
Pentwater Capital Management LP 2,419,800$63,641,0000.47%
Hudson Bay Capital Management LP 105,000$2,762,0000.13%
CMT Asset Management Ltd 67,900$1,786,0000.12%
Citadel Advisors 1,980,900$52,098,0000.07%
SG Americas Securities, LLC 500,000$2,500,0000.02%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders